Coinbase CEO Brian Armstrong discusses the company's transformation into an 'everything exchange' for diverse assets, the explosive growth of stablecoin payments, and the emerging 'agentic finance' economy where AI agents will manage their own crypto wallets. He also unveils his second venture, New Limit, which uses AI-driven epigenetic reprogramming to reverse cellular aging, targeting diseases like alcoholic liver disease with a phase one clinical trial next year.
Summarized by Podsumo
Coinbase is building an 'everything exchange' for stocks, commodities, crypto, and prediction markets, with 88% of its revenue now coming from non-Bitcoin trading.
Stablecoins are enabling ultra-cheap microtransactions (under 1 cent, under 1 second), which is critical for AI agent commerce where 76% of transactions are under 30 cents.
Coinbase is creating tools for AI agents to have their own bank accounts using self-custodial wallets and crypto rails, bypassing traditional KYC requirements.
Brian Armstrong's second company, New Limit, uses AI for epigenetic reprogramming to reverse cellular aging, targeting liver, vasculature, and immune cells with a phase one clinical trial in 2024.
Armstrong advocates for 'freedom cities' or special economic zones in the US to foster innovation in areas like drone delivery, nuclear power, and crypto, bypassing overly restrictive regulations.
"We don't want the AIs to be unbanked. They deserve financial services as well."
— Brian Armstrong
"There'll be more agents than humans in the not too distant future. It kind of stands to reason that the agentic economy will be bigger than the human economy."
— Brian Armstrong
"I think it's good for more people to contribute to civilizational progress... It's easy to be a critic. It's better to try to be a builder."
— Brian Armstrong